Boston Therapeutics, Inc. Contracts & Agreements

105 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 1, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Description of Securities of Nanomix Corporation
Boston Therapeutics, Inc.
2023
Offer Letter for Chris Hetterly, dated November 15, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Subscription Agreement, dated October 21, 2022, by and between the Company and the Investor
Subscription Agreements
Boston Therapeutics, Inc.
2022
Offer Letter, dated July 21, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Form of Warrant assumed as part of the Nanomix Merger
Merger Agreements
Boston Therapeutics, Inc.
2022
Offer Letter, dated February 28, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Description of Securities of Nanomix Corporation
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Development and License Agreement, dated September 26, 2017 by and between RedPharm (Beijing) Biotechnology Co., Ltd. and Medical Technology Associates II, Inc. and Nanomix, Inc
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
CA
2022
First Amendment to Development and License Agreement, dated September 1, 2018 by and between RedPharm (Beijing) Biotechnology Co., Ltd. and Medical Technology Associates II, Inc....
License Agreements
Boston Therapeutics, Inc.
2022
Form of Warrant, dated March 23, 2022
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Securities Purchase Agreement, dated March 23, 2022
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Consent, Amendment and Waiver, dated March 22, 2022
Waiver Agreements
Boston Therapeutics, Inc.
2022
Form of Senior Secured Convertible Note, dated February 28, 2022
Note Agreements
Boston Therapeutics, Inc.
2022
Form of Warrant, dated February 28, 2022
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Securities Purchase Agreement, dated February 28, 2022
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Consent, Amendment and Waiver, dated February 24, 2022
Waiver Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Form of Senior Secured Convertible Note, dated June 25, 2021
Note Agreements
Boston Therapeutics, Inc.
2021
Form of Warrant, dated June 25, 2021
Warrant Agreements
Boston Therapeutics, Inc.
2021
Securities Purchase Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto
Purchase Agreements
Boston Therapeutics, Inc.
2021
Registration Rights Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto
Registration Rights Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Security and Pledge Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc, each of the Companys subsidiaries and HT Investments MA LLC, in its capacity as...
Security Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Guaranty, dated June 25, 2021, by each of the Companys subsidiaries in favor of HT Investments MA LLC, in its capacity as collateral agent
Guaranty Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Form of Exchange Agreement, dated June 25, 2021, with existing holders of convertible promissory notes
Exchange Agreements
Boston Therapeutics, Inc.
2021
Form of Promissory Note dated April 30, 2021
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Form of 10% Promissory Note issued by Nanomix, Inc. to Boston Therapeutics Inc
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Agreement and Plan of Merger, dated February 2, 2021, by and between Boston Therapeutics, Inc.., BTHE Acquisition Inc. and Nanomix, Inc
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2021
Certificate of Designation Series B Preferred Stock
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2021
Form of Exchange Agreement
Exchange Agreements
Boston Therapeutics, Inc.
2021
Form of Debt Settlement and Release Agreement
Settlement Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Unwind Agreement between Boston Therapeutics, Inc., Cure DM, Inc. and Cure DM Group Holdings, LLC signed August 6, 2019
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2019
License Agreement between Boston Therapeutics, Inc. and Level Brands, Inc. dated June 26, 2018
License Agreements
Boston Therapeutics, Inc.
2018
Form of Promissory Note dated June 12, 2018
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2018
Form of Contribution Agreement between Boston Therapeutics, Inc., CureDM Group, LLC and the members of CureDM Group Holdings, LLC dated January 1, 2018
Contribution Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2018
Executive Retention Agreement between Boston Therapeutics, Inc. and Loraine Upham
Retention Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2018
Form of Securities Purchase Agreement entered between Boston Therapeutics, Inc. dated August 14, 2017
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Certificate of Designation dated August 14, 2017
Boston Therapeutics, Inc.
2017
Form of Common Stock Purchase Warrant issued to the Investors
Warrant Agreements
Boston Therapeutics, Inc.
2017
Securities Purchase Agreement entered between Boston Therapeutics, Inc. and CJY Holdings Limited
Purchase Agreements
Boston Therapeutics, Inc.
2017
Form of 6% Subordinated Convertible Debenture
Debenture Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Form of Stock Purchase Warrants
Stock Agreements
Boston Therapeutics, Inc.
2017
Letter Agreement dated March 27, 2017 entered between Boston Therapeutics, Inc. and Carl W. Rausch
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Form of Securities Purchase Agreement entered with the August 2016 Accredited Investors
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Form of 6% Senior Convertible Debuenture
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Form of Stock Purchase Warrant
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2016
Letter Agreement between the Company and CJY Holdings Limited dated August 12, 2016
Boston Therapeutics, Inc.
2016
Executive Employment Agreement between the Company and Carl. W. Rausch dated August 12, 2016
Employment Agreements
Boston Therapeutics, Inc.
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated June 28, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated May 6, 2016
Boston Therapeutics, Inc.
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 11, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated November 30, 2015
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Warrant Repricing and Exercise Agreement entered by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated November 12, 2015, effective June 15, 2015
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2015
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Form of Securities Purchase Agreement by and between Boston Therapeutics, Inc. and CJY Holdings Limited
Purchase Agreements
Boston Therapeutics, Inc.
2015
Form of 10% Convertible Promissory Note issued to CJY Holdings Limited
Note Agreements
Boston Therapeutics, Inc.
2015
Letter Agreement by and between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015
Purchase Agreements
Boston Therapeutics, Inc.
2015
Convertible Promissory Note between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
Convertible Note between Boston Therapeutics, Inc. and JMJ Financial dated as of March 18, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
FL
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015
Purchase Agreements
Boston Therapeutics, Inc.
2015
Convertible Promissory Note between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015
Purchase Agreements
Boston Therapeutics, Inc.
2015
Convertible Promissory Note between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
UT
2015
Warrant to Purchase Shares of Common Stock between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015
Warrant Agreements
Boston Therapeutics, Inc.
2015
Form of Warrant issued to investors in this offering
Warrant Agreements
Boston Therapeutics, Inc.
2015
Form of Subscription Agreement
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Marketing Agreement between Boston Therapeutics, Inc. Benchworks SD LLC dated as of May 14, 2014
Marketing Agreements
Boston Therapeutics, Inc.
2014
Separation Agreement and General Release between Boston Therapeutics, Inc. and Kenneth A. Tassey, Jr., effective June 30, 2014
Separation Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2014
COMMON STOCK PURCHASE WARRANT BOSTON THERAPEUTICS, INC.
Warrant Agreements
Boston Therapeutics, Inc.
2014
Form of Investor Warrant
Warrant Agreements
Boston Therapeutics, Inc.
2013
Form of Placement Agent Warrant
Warrant Agreements
Boston Therapeutics, Inc.
2013
Technology Assignment Agreement dated as of August 24, 2009 by and between the Company and David Platt
Assignment Agreements
Boston Therapeutics, Inc.
2013
Boston Therapeutics, Inc. Amended and Restated 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
2013
Boston Therapeutics, Inc. 2011 Non-Qualified Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
2013
Promissory Note dated as of February 9, 2010 issued by the Company to David Platt
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2013
Agreement and Plan of Merger dated November 10, 2010 by and among Avanyx Therapeutics, Inc. and Boston Therapeutics, Inc
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Certificate of Merger
Merger Agreements
Boston Therapeutics, Inc.
2013
Form of Subscription Agreement dated June 21, 2011, among Boston Therapeutics, Inc. and the Investors named therein
Subscription Agreements
Boston Therapeutics, Inc.
2013
License and Manufacturing Agreement between Boston Therapeutics, Inc. and Advance Pharmaceutical Company Limited effective as of June 24, 2011
License Agreements
Boston Therapeutics, Inc.
2013
Employment Agreement between Boston Therapeutics, Inc. and Ken Tassey dated as of August 11, 2011
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2013
Unit Purchase Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2013
Registration Rights Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended
Registration Rights Agreements
Boston Therapeutics, Inc.
2013
Form of Investor Warrant
Warrant Agreements
Boston Therapeutics, Inc.
2013
Form of Private Placement Warrant
Warrant Agreements
Boston Therapeutics, Inc.
2013
Boston Therapeutics, Inc. Amended and Restated 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Unit Purchase Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2013
Registration Rights Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended
Registration Rights Agreements
Boston Therapeutics, Inc.
2013
Amended and Restated 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
2013
Boston Therapeutics, Inc. OTCQB:BTHE1750 Elm Street Suite 103Manchester, NH03104Tel: (603) 935-9799Fax: (603) 685-4784www.bostonti.com
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Specimen Warrant
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Technology Assignment Agreement dated as of August 24, 2009 by and between the Company and David Platt
Assignment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Avanyx Therapeutics, Inc. 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Boston Therapeutics, Inc. 2011 Non-Qualified Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Promissory Note dated as of February 9, 2010 issued by the Company to David Platt
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2012
Agreement and Plan of Merger dated November 10, 2010 by and among Avanyx Therapeutics, Inc. and Boston Therapeutics, Inc
Merger Agreements
Boston Therapeutics, Inc.
2012
Certificate of Merger
Merger Agreements
Boston Therapeutics, Inc.
2012
Form of Subscription Agreement dated June 21, 2011, among Boston Therapeutics, Inc. and the Investors named therein
Subscription Agreements
Boston Therapeutics, Inc.
2012
License and Manufacturing Agreement between Boston Therapeutics, Inc. and Advance Pharmaceutical Company Limited effective as of June 24, 2011
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Employment Agreement between Boston Therapeutics, Inc. and Ken Tassey dated as of August 11, 2011
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2012
Certain portions of this exhibit, as indicated by [***] , have been omitted, pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of...
Exchange Agreements
Boston Therapeutics, Inc.
2011
EMPLOYMENT AGREEMENT
Employment Agreements
Boston Therapeutics, Inc.
2011
BOSTON THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT
Subscription Agreements
Boston Therapeutics, Inc.
2011
TECHNOLOGY ASSIGNMENT AGREEMENT
Assignment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2010
AVANYX THERAPEUTICS, INC. 2010 STOCK PLAN
Stock Agreements
Boston Therapeutics, Inc.
2010
PROMISSORY NOTE $78,820.28Made as of February 9, 2010
Note Agreements
Boston Therapeutics, Inc.
2010